New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...

Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...

St. Luke's Health-Memorial Hospital Lufkin recently announced a significant advancement in cardiovascular care, becoming the first and only hospital in Deep East Texas to successfully perform a ...

New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...

Having a residual shunt after percutaneous patent foramen ovale (PFO) closure was associated with an elevated risk of stroke or transient ischemic attack (TIA) recurrence years after the procedure, ...

The first-ever guidelines for interventional cardiologists using percutaneous patent foramen ovale closure recommend expanding the use of the procedure beyond the Food and Drug Administration-approved ...

Said Wu: "And the procedure takes about 30 to 60 minutes, and then if everything goes OK, the patient can leave the same day." Wu says the PFO procedure should involve a collaboration between a ...

A 46-year-old female with no previously documented illnesses presented with 15 months of diarrhea, abdominal pain, and flushing after alcohol consumption. Abdominal CT showed multiple hepatic masses, ...

At long last, debate over the value of patent foramen ovale (PFO) closure versus medical therapy for the secondary prevention of cryptogenic stroke may finally be winding down, following the ...

When Dr. M. Soubhi Azzouz joined Western Slope Cardiology last year in Grand Junction, he brought with him a skill set that would allow the practice to expand their heart surgery practice for local ...

Current evidence on the efficacy of percutaneous closure of patent foramen ovale (PFO) for recurrent migraine is inadequate in quality and quantity. The evidence on safety shows a small incidence of ...